Disease | hyperthermia |
Comorbidity | C0024299|lymphoma |
Sentences | 16 |
PubMedID- 23672349 | Significant improvements in the lymphoma subscale (including symptoms of pain, fever, itching, fatigue, weight loss, loss of appetite, and other patient concerns), fact-general, fact-lym trial outcome index, and fact-lym total were also observed with ruxolitinib versus bat starting at week 8 and continuing thereafter. |
PubMedID- 22989822 | Clinical features of 66 lymphoma patients presenting with a fever of unknown origin. |
PubMedID- 26291417 | Usefulness of random skin biopsy as a diagnostic tool of intravascular lymphoma presenting with fever of unknown origin. |
PubMedID- 26463422 | We observed a lymphoma in a patient with q fever that prompted us to investigate the association between the two diseases. |
PubMedID- 22332684 | Intravascular large b-cell lymphoma, a cause of fever of unknown origin in the elderly. |
PubMedID- 24317848 | Conclusions: this observational study suggested that adjunctive g-csf may confer clinical benefits among solid tumor and lymphoma patients with established febrile neutropenia. |
PubMedID- 24684228 | History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in patients with non-hodgkin lymphoma not receiving granulocyte colony-stimulating factor prophylaxis. |
PubMedID- 23255844 | Use of zidovudine or trimethoprim/sulfamethoxazole or bone marrow involvement of lymphoma was not associated with neutropenic fever or febrile prolonged neutropenia (data not shown). |
PubMedID- 22117311 | [two cases of successfully treated intravascular lymphoma presenting with fever and dyspnea]. |
PubMedID- 21413829 | Empiric sc therapy was found to be as effective as carbapenem monotherapy in pediatric febrile neutropenic patients with lymphoma and solid tumors. |
PubMedID- 26027994 | Hiv-negative primary bone marrow hodgkin lymphoma manifesting with a high fever associated with hemophagocytosis as the initial symptom: a case report and review of the previous literature. |
PubMedID- 23917942 | The male patient, who was 37 years of age and undergoing therapy for non-hodgkin's lymphoma, was admitted with cough, fever, dyspnea and acute hypoxemic respiratory failure. |
PubMedID- 26532567 | Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with non-hodgkin's lymphoma in greece. |
PubMedID- 25252614 | Background: the primary objective was to describe the total direct inpatient costs among solid tumor and lymphoma patients with chemotherapy-induced febrile neutropenia (fn) and the factors that were associated with higher direct cost. |
PubMedID- 26111699 | [muscle tissue lymphoma presenting only with fever of unknown origin: a case report and literature review]. |
PubMedID- 22972488 | Primary prophylaxis with granulocyte colony-stimulating factor (gcsf) reduces the incidence of febrile neutropenia in patients with non-hodgkin lymphoma (nhl) receiving chop chemotherapy treatment without adversely affecting their quality of life: cost-benefit and quality of life analysis. |
Page: 1